Ratings Balaji Amines Limited NSE India S.E.

Equities

BALAMINES

INE050E01027

Market Closed - NSE India S.E. Other stock markets 07:40:29 2024-05-21 EDT			5-day change	1st Jan Change
2,263 ^INR	+2.34%		+3.26%	-15.18%

05-10	Transcript : Balaji Amines Limited, Q4 2024 Earnings Call, May 10, 2024
05-08	Balaji Amines' Consolidated Profit Jumps in Fiscal Q4; Shares Surge 10%	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

The group's high margin levels account for strong profits.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.2 times its estimated earnings per share for the ongoing year.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last few months, analysts have been revising downwards their earnings forecast.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-15.18%	887M	-
ECOLAB INC.	+18.46%	67.02B	A-
SIKA AG	+3.18%	49.69B	A-
GIVAUDAN SA	+20.44%	42.41B	B+
FUJIFILM HOLDINGS CORPORATION	+23.39%	26.65B	A-
EMS-CHEMIE HOLDING AG	+12.41%	19.62B	C+
CELANESE CORPORATION	+0.01%	17.1B	B+
SYMRISE AG	+4.18%	15.64B	B+
POSCO FUTURE M CO., LTD.	-26.74%	15.43B	A-
ALBEMARLE CORPORATION	-11.81%	15.3B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes